Structure-activity relationships of a potent and selective Ca2+ Receptor antagonist.

被引：0
|
作者：
Callahan, JF
Barton, L
Bryan, WM
Burgess, JL
DelMar, R
Fox, J
Gleason, JG
Gorycki, P
Gowen, M
Huffman, WF
Lago, AM
Nemeth, E
Nguyen, TT
Smith, BR
Stroup, G
Bhatnagar, PK
机构：
[1] SmithKline Beecham, Med Chem, Collegeville, PA 19426 USA
[2] SmithKline Beecham, DMPK, Collegeville, PA USA
[3] SmithKline Beecham, Bone & Cartilage Biol, Collegeville, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页码：U35 / U35
页数：1
相关论文
共 50 条
  • [41] Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists
    Pal, Shantanu
    Choi, Won Jun
    Choe, Seung Ah
    Heller, Cara L.
    Gao, Zhan-Guo
    Chinn, Moshe
    Jacobson, Kenneth A.
    Hou, Xiyan
    Lee, Sang Kook
    Kim, Hea Ok
    Jeong, Lak Shin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (10) : 3733 - 3738
  • [42] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF CONFORMATIONALLY CONSTRAINED CYANOGUANIDINES: POTENT AND SELECTIVE HISTAMINE H4 RECEPTOR AGONISTS
    Geyer, R.
    Igel, P.
    Bernhardt, G.
    Buschauer, A.
    INFLAMMATION RESEARCH, 2010, 59 : S353 - S354
  • [43] Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.
    Kim, YC
    Jung, KY
    Kim, SK
    Gao, ZG
    Gross, AS
    Melman, N
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U53 - U53
  • [44] Structure-activity relationship of xanthines and skeletal muscle ryanodine receptor/Ca2+ release channel
    Liu, W
    Meissner, G
    PHARMACOLOGY, 1997, 54 (03) : 135 - 143
  • [45] Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen
    Butts, Arielle
    Martin, Jennifer A.
    DiDone, Louis
    Bradley, Erin K.
    Mutz, Mitchell
    Krysan, Damian J.
    PLOS ONE, 2015, 10 (05):
  • [46] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [47] Agonist-antagonist structure-activity relationships of thrombin receptor tethered ligand peptide
    Fujita, T
    Nose, T
    Nakajima, M
    Inoue, Y
    Nakamura, N
    Inoue, T
    Costa, T
    Shimohigashi, Y
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 202 - 204
  • [48] Structure-activity relationships of the systemically active peptide kappa opioid receptor antagonist zyklophin
    Joshi, Anand A.
    Murray, Thomas F.
    Aldrich, Jane V.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [49] Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligands
    Farmer, LJ
    Zhi, L
    Jeong, S
    Kallel, EA
    Croston, G
    Flatten, KS
    Heyman, RA
    Nadzan, AM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) : 2747 - 2752
  • [50] Highly selective endothelin antagonists for ET(A) receptor: Synthesis and structure-activity relationships
    Liu, G
    Henry, KJ
    Szczepankiewicz, BG
    Winn, M
    Boyd, SA
    Mantei, RA
    Wasicak, J
    vonGeldern, TW
    WuWong, JR
    Chiou, W
    Dixon, D
    Opgenorth, TJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 193 - MEDI
12345